Similar results have also been recorded in a BCR-ABL ALL cell line, and it was reported that the use of the same N-cadherin antagonist peptide inhibits the adhesion of ALL cells to fibroblasts [119]. This evidence concerns the gene CDH2 and acute lymphoblastic leukemia.